Peering Into Ocugen's Recent Short Interest

BenzingaAug 9 16:15 ET

Earnings Call: Ocugen Reports Progress and Financials in Q2 2024

InvestingAug 9 13:02 ET

Ocugen (OCGN) Receives a Buy From Noble Financial

TipRanksAug 9 09:28 ET · Ratings

Buy Rating on Ocugen: Strong Financials and Promising Clinical Progress

TipRanksAug 9 07:16 ET · Ratings

Ocugen (OCGN) Q2 2024 Earnings Call Transcript

Yahoo FinanceAug 8 17:30 ET

Express News | Ocugen's Cash, Cash Equivalents, And Restricted Cash Totaled $16M As Of June 30, 2024, Subsequent To June 30, 2024, The Company Closed A Public Offering With Net Proceeds Of $32.6 Million—Extending Its Expected Cash Runway Into The Third Quarter Of 2025

BenzingaAug 8 06:54 ET